This Center for Population Health and Health Disparities (CPHHD) is being proposed to address significant gaps in our knowledge about factors that predict prostate cancer outcomes, and in particular the causes of disparity in prostate cancer outcomes between men of African and Caucasian descent. The mission of the proposed center is to 1) study the complex interaction of biological, clinical, behavioral, and environmental factors predictive of outcomes following a prostate cancer diagnosis, 2) evaluate how these factors explain disparities in prostate cancer outcomes by etnicity, and 3) disseminate this information to at-risk populations and the public health community. The CPHHD builds on our existing multidisciplinary research resources that include studies of the genetics, quality of life, patterns of care, physical environment, and social environment after the diagnosis of prostate cancer. This research requires transdisciplinary collaboration across molecular biology, genetic epidemiology, sociology, the behavioral sciences, and health policy. The proposed research has implications for clinical and public health practice, with potential to catalyze critical improvements in the prevention and treatment of prostate cancer. The CPHHD will address the following Specific Aims:
Specific Aim 1 : To undertake four highly interrelated research projects aimed at identifying factors that influence prostate cancer outcomes. These projects will evaluate the role of behavioral and environmental factors associated with physician and patient screening practices, screening behavior and genotypes on prostate cancer clinical outcomes, social and environmental factors on quality of life, and discrimination on treatment and medical outcomes after prostate cancer diagnoses.
Specific Aim 2 : To create three specialized cores to serve the needs of the CPHHD. These include: (1) an Administration Core to oversee and evaluate the CPHHD; (2) a Community Education and Dissemination Core to facilitate ongoing interactions with our community partners, and and to translate the information gained from this research to the public health community and general population; and (3) a Biomedical Informatics Core to provide integrated data management and to construct a comprehensive model of the multivariate biological, behavioral, social, and environmental factors on prostate cancer outcomes.
Specific Aim 3 : To solicit and support a series of focused high priority developmental (pilot) research projects. These projects will be chosen to extend the primary research projects to additional studies of cancer screening, biological interactions, statistical model building for the integration of complex data from various disciplines. The goal of these developmental projects is to expand the scope of the research proposed in the four Projects described here and to enhance the multidisciplinary research team with members representing additional disciplines and expertise.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA105641-02
Application #
6802989
Study Section
Special Emphasis Panel (ZES1-SET-A (P6))
Program Officer
Heurtin-Roberts, Suzanne H
Project Start
2003-09-24
Project End
2008-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$1,635,087
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Lynch, Shannon M; Mitra, Nandita; Ravichandran, Krithika et al. (2017) Telomere Length and Neighborhood Circumstances: Evaluating Biological Response to Unfavorable Exposures. Cancer Epidemiol Biomarkers Prev 26:553-560
Rebbeck, Timothy R (2017) Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography. Semin Radiat Oncol 27:3-10
Jeffers, Abra; Sochat, Vanessa; Kattan, Michael W et al. (2017) Predicting Prostate Cancer Recurrence After Radical Prostatectomy. Prostate 77:291-298
Busch, Evan L; Hornick, Jason L; Umeton, Renato et al. (2017) Somatic mutations in CDH1 and CTNNB1 in primary carcinomas at 13 anatomic sites. Oncotarget 8:85680-85691
Lynch, Shannon M; Peek, M K; Mitra, Nandita et al. (2016) Race, Ethnicity, Psychosocial Factors, and Telomere Length in a Multicenter Setting. PLoS One 11:e0146723
Yamoah, Kosj; Zeigler-Johnson, Charnita M; Jeffers, Abra et al. (2016) The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer. BMC Cancer 16:557
Yamoah, Kosj; Deville, Curtiland; Vapiwala, Neha et al. (2015) African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urol Oncol 33:70.e15-22
Yamoah, Kosj; Walker, Amy; Spangler, Elaine et al. (2015) African-american race is a predictor of seminal vesicle invasion after radical prostatectomy. Clin Genitourin Cancer 13:e65-72
Rebbeck, Timothy R; Haas, Gabriel P (2014) Temporal trends and racial disparities in global prostate cancer prevalence. Can J Urol 21:7496-506
Lynch, Shannon M; Rebbeck, Timothy R (2013) Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: a multilevel approach. Cancer Epidemiol Biomarkers Prev 22:485-95

Showing the most recent 10 out of 55 publications